3 days popular7 days popular1 month popular3 months popular

NICE publishes new guideline on most deadly form of skin cancer

NICE has published its first guideline on melanoma which aims to reduce the numbers of people dying from the disease, and addresses the wide variations across the country in diagnosis and treatment. Melanoma is the third most common skin cancer in the UK and accounts for more cancer deaths than all other skin cancers combined. [...]

Drugs for impotence do not increase risk of melanoma

Using drugs for impotence does not increase the risk of malignant melanoma, researchers from UmeƄ University in Sweden conclude in a publication in JAMA, a top US medical journal. These results contradict previous research indicating such an association. Last year, a research team from Harvard University in Boston, United States, reported that Viagra, a phosphodiesterase [...]

Combination of Novartis drugs Tafinlar and Mekinist shows significant survival benefit in patients with metastatic melanoma

Novartis has announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar® (dabrafenib) and Mekinist® (trametinib) compared to Tafinlar monotherapy alone. This is the first combination of BRAF/MEK inhibitors to demonstrate a statistically significant overall survival benefit [...]

Pivotal study showing talimogene laherparepvec showed durable response rates in metastatic melanoma published

Amgen has announced the publication of primary results from the Phase 3 OPTiM study in the Journal of Clinical Oncology (JCO). The data published in JCO, which were previously presented at the Annual Meetings of the American Society of Clinical Oncology (ASCO) in 2013 and 2014, demonstrated a significantly higher durable response rate (DRR) in [...]

Melanoma, pediatric cancer and lymphoma dominate research from NYU Langone at ASCO 2015

Plasma cell disorders and epidemiology studies also play a prominent role NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will have a high profile at the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), with researchers presenting close to 30 abstracts accepted for oral, poster and publication presentations. [...]